THOMPSON - Vale Base Metals has signed a deal to partner with three companies in a consortium that will invest up to $280 million in its Thompson Mine Complex in Manitoba. The new owners aim to double ...

Complex is expanding its cultural reach with the first-ever Complex Market — a curated retail experience coinciding with NBA All-Star Weekend that will be hosted by designer and influential streetwear ...

EXCLUSIVE: Disney Entertainment Television has chosen its participants for the 2025-26 Directing and Writing Programs, talent development initiatives which connect emerging writers and directors with ...

For those who have used PCs for a sufficiently long time, you probably remember trying to insert a USB plug into a port, only to have to flip it upside-down to get it in there. The advent of USB-C in ...

Sarah Bradley is a writer with six years of experience creating personal essays, reported features, and content related to health and parenting topics. Susan Bard, MD, is a board-certified general and ...

Point Park University has announced a partnership with HXOUSE, the Toronto-based think center cofounded by La Mar Taylor and Abel “The Weeknd” Tesfaye, to launch the HXOUSE x Point Park Creative ...

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...

Anthropic is launching Cowork for Claude as a research preview. It's built upon Claude Code and can automate complex tasks. However, it comes with security risks. Anthropic is testing a new feature ...

Pictured is a U.S. Air Force load master with the 4th Airlift Squadron directing the placement of a High Mobility Artillery Rocket System onto a C-17 Globemaster III at the Royal Australian Air Force ...

At the heart of Netflix's "Stranger Things" is a girl with a "011" tattoo on her wrist. Her name is Jane, but she is almost always called Eleven. Though unusual, it's not out of the question for ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...